© 2020 MJH Life Sciences and OncLive. All rights reserved.
August 13, 2020
Heather S. Han, MD, discusses the importance of pathologic complete response in breast cancer.
March 30, 2018
Heather S. Han, MD, research director, medical oncologist, Department of Breast Oncology, Moffitt Cancer Center, discusses the differences between CDK 4/6 inhibitors, and their efficacy as both single- and combination agents.